Vero Biotech's Series E Round

Vero Biotech raised a round of funding on September 29, 2017.

Vero Biotech, fka GeNO, is a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to address unmet medical needs of patients wi…

Articles about Vero Biotech's Series E Round: